Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System…
Recall Z-1648-2023, part of FDA recall event 92187. See Cytrellis Biosystems's company page.
Cytrellis Biosystems, Inc. started this Class II device recall on Apr 7, 2023 (voluntary: firm initiated); FDA lists it as completed.
- Classification: Class II
- Started: Apr 7, 2023
- Status: Completed
Irregular core patterns could cause potential overlap of cores at the 8% setting, potentially leading to prolonged healing, irregularities in patient skin texture post-treatment, and/or scarring.
- Product
- Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System intended for the treatment of moderate and severe wrinkles in the mid and lower face. Model #: Gen 4
- Quantity
- 89 units
- Lots and codes
- UDI-DI: B933ELCON010 All serial numbers
- Distribution
- Nationwide
- Recalling firm
- Cytrellis Biosystems, Inc., Woburn, MA, United States
- How the firm notified
- FDA classified
- May 26, 2023
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports